Swiss Life Holding


Solid H1 20 figures, all targets confirmed despite COVID-19

13/08/20 -"• Net profit attributable to shareholders decreased by 13% to CHF533m for H1 20 • Gross written premiums were down by 17% for H1 20 due to a special Swiss effect in 2019 but +2% on an adjusted ..."

Pages
47
Language
English
Published on
13/08/20
You may also be interested by these reports :
11/02/26
Storebrand reported strong Q4 results, above expectations, mainly driven by the insurance and asset management businesses, while unit-linked and ...

10/02/26
Talanx has released solid preliminary FY25 results, slightly above consensus, although only limited details were provided at this stage. The full ...

06/02/26
Sampo’s FY25 results were ahead of our expectations, mainly due to a higher-than-anticipated financial result driven by capital gains. We have ...

06/02/26
Sampo delivered a solid set of FY25 results, although momentum faded in Q4 in terms of both GWP growth and profitability, particularly in the UK. ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO